Medical Device | Healthcare | Biotechnology | Pharmaceuticals

What are the key factors driving growth in Multiplex Assays Market? In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of Companion Diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays. How global multiplex assays market will grow in coming years? The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314 Consumables Segment to Dominate The Market: On the basis of product & service, the market is broadly segmented into instruments, consumables, and software & services. The consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market....

The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of Companion Diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314 Opportunity: Monitoring of biosimilars in autoimmune diseases Anti-TNF-alpha biologics are proving to be an effective treatment for autoimmune diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). With the increasing healthcare costs as well as patent expirations, the number of R&D activities focusing on the development of biosimilars have increased over the last few years. The launch of biosimilars in the market is increasing t...

The report  “ Multiplex Assays Market  Product (Consumable (Kits & Reagents, Panels), Type 9nucleic Acid-Based, Protein-Based), Technology (PCR, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) – Global Forecast to 2021″ , provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the multiplex assays market along with the estimates and forecasts of the revenue. Browse 111 market data Tables and 59 Figures spread through 173 Pages and in-depth TOC on  “Multiplex Assays Market Product (Consumable (Kits & Reagents, Panels), Type 9nucleic Acid-Based, Protein-Based), Technology (PCR, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) – Global Forecast to 2021”   http://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html Early buyers wil...

The applications segment of the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered by multiplex assays are driving the growth of this segment. North America is expected to account for the largest share of the multiplex assays market in 2016. This region is estimated to account for 44.7% of the total market. Europe is the second-largest source, this regional market is driven by the availability of government funds. Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=61593314 The adoption of companion diagnostics for increasing safety & efficacy of therapies, need for effective analytical platforms in research to reduce operational costs, advantage...